Applied Therapeutics' Govorestat Faces Unclear Regulatory Path After FDA Rejection, RBC Says
In This Article:
Applied Therapeutics' (APLT) lead drug govorestat faces "significant uncertainties" around a regulat
Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.